Clinical Trials Browser

Withdrawn × Glioma × Topotecan × Clear all

NCT03193463 2019-03-01

Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsy

Phase EARLY_PHASE1 Withdrawn

Glioma